These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24164697)

  • 1. Cost-effectiveness of a national exercise referral programme for primary care patients in Wales: results of a randomised controlled trial.
    Edwards RT; Linck P; Hounsome N; Raisanen L; Williams N; Moore L; Murphy S
    BMC Public Health; 2013 Oct; 13():1021. PubMed ID: 24164697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the effectiveness and cost effectiveness of the National Exercise Referral Scheme in Wales, UK: a randomised controlled trial of a public health policy initiative.
    Murphy SM; Edwards RT; Williams N; Raisanen L; Moore G; Linck P; Hounsome N; Din NU; Moore L
    J Epidemiol Community Health; 2012 Aug; 66(8):745-53. PubMed ID: 22577180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.
    Pavey TG; Anokye N; Taylor AH; Trueman P; Moxham T; Fox KR; Hillsdon M; Green C; Campbell JL; Foster C; Mutrie N; Searle J; Taylor RS
    Health Technol Assess; 2011 Dec; 15(44):i-xii, 1-254. PubMed ID: 22182828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.
    Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E
    Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pragmatic randomised controlled trial of the Welsh National Exercise Referral Scheme: protocol for trial and integrated economic and process evaluation.
    Murphy S; Raisanen L; Moore G; Edwards RT; Linck P; Williams N; Ud Din N; Hale J; Roberts C; McNaish E; Moore L
    BMC Public Health; 2010 Jun; 10():352. PubMed ID: 20565846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of exercise referral schemes.
    Anokye NK; Trueman P; Green C; Pavey TG; Hillsdon M; Taylor RS
    BMC Public Health; 2011 Dec; 11():954. PubMed ID: 22200193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving an exercise referral scheme to remote delivery during the Covid-19 pandemic: an observational study examining the impact on uptake, adherence, and costs.
    Newby K; Howlett N; Wagner AP; Smeeton N; Fakoya O; Lloyd N; Freethy I; Bontoft C; Brown K; McKibben MA; Petherick A; Wills W
    BMC Public Health; 2024 Aug; 24(1):2324. PubMed ID: 39192229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AESOPS: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users in primary care.
    Watson JM; Crosby H; Dale VM; Tober G; Wu Q; Lang J; McGovern R; Newbury-Birch D; Parrott S; Bland JM; Drummond C; Godfrey C; Kaner E; Coulton S;
    Health Technol Assess; 2013 Jun; 17(25):1-158. PubMed ID: 23796191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitating adherence to physical activity: exercise professionals' experiences of the National Exercise Referral Scheme in Wales: a qualitative study.
    Moore GF; Moore L; Murphy S
    BMC Public Health; 2011 Dec; 11():935. PubMed ID: 22171615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people: a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial).
    Cockayne S; Rodgers S; Green L; Fairhurst C; Adamson J; Scantlebury A; Corbacho B; Hewitt CE; Hicks K; Hull R; Keenan AM; Lamb SE; McIntosh C; Menz HB; Redmond A; Richardson Z; Vernon W; Watson J; Torgerson DJ
    Health Technol Assess; 2017 Apr; 21(24):1-198. PubMed ID: 28621259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of offering free leisure centre memberships to physically inactive members of the public receiving state benefits: a case study.
    Verhoef TI; Trend V; Kelly B; Robinson N; Fox P; Morris S
    BMC Public Health; 2016 Jul; 16():616. PubMed ID: 27449787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: the HEALTH RCT.
    Cooper K; Breeman S; Scott NW; Scotland G; Hernández R; Clark TJ; Hawe J; Hawthorn R; Phillips K; Wileman S; McCormack K; Norrie J; Bhattacharya S
    Health Technol Assess; 2019 Sep; 23(53):1-108. PubMed ID: 31577219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
    Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
    Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial.
    Ahern AL; Wheeler GM; Aveyard P; Boyland EJ; Halford JCG; Mander AP; Woolston J; Thomson AM; Tsiountsioura M; Cole D; Mead BR; Irvine L; Turner D; Suhrcke M; Pimpin L; Retat L; Jaccard A; Webber L; Cohn SR; Jebb SA
    Lancet; 2017 Jun; 389(10085):2214-2225. PubMed ID: 28478041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the cost-effectiveness of pay-for-performance in primary care in the UK.
    Pandya A; Doran T; Zhu J; Walker S; Arntson E; Ryan AM
    BMC Med; 2018 Aug; 16(1):135. PubMed ID: 30153827
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.